# EDGAR Filing Document

**Accession Number:** 0001968053
**File Stem:** 0001213900-25-067358
**Filing Date:** 2025-7
**Character Count:** 7253
**Document Hash:** 438777f0650756b90343bbcf3bfdbbc4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-067358.hdr.sgml**: 20250724

**ACCESSION NUMBER**: 0001213900-25-067358

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250724

**DATE AS OF CHANGE**: 20250724

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Alpha Tau Medical Ltd.
- **CENTRAL INDEX KEY:** 0001871321
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94982
- **FILM NUMBER:** 251147352

**BUSINESS ADDRESS:**
- **STREET 1:** KIRYAT HAMADA 5
- **CITY:** JERUSALEM
- **STATE:** L3
- **ZIP:** 9777605
- **BUSINESS PHONE:** 972-3-577-4115

**MAIL ADDRESS:**
- **STREET 1:** KIRYAT HAMADA 5
- **CITY:** JERUSALEM
- **STATE:** L3
- **ZIP:** 9777605
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sofer Uzi
- **CENTRAL INDEX KEY:** 0001968053

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G

**MAIL ADDRESS:**
- **STREET 1:** C/O ALPHA TAU MEDICAL LTD.
- **STREET 2:** KIRYAT HAMADA STREET 5
- **CITY:** JERUSALEM
- **STATE:** L3
- **ZIP:** 9777605

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**Issuer:** Alpha Tau Medical Ltd.

**Title of Class of Securities:** Ordinary Shares, no par value

**CUSIP Number:** M0740A108

**Date of Event Which Requires Filing of this Statement:** 12/31/2022

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [ ] Rule 13d-1(c)

- [x] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>Uzi Sofer | Names of Reporting Persons<br>Uzi Sofer |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>L3 | Citizenship or Place of Organization<br>L3 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>13702361.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>13702361.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>13702361.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>13702361.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>15.8% | Percent of Class Represented by Amount in Row (9)<br>15.8% |
| 12. | Type of Reporting Person (See Instructions)<br>IN | Type of Reporting Person (See Instructions)<br>IN |

---

**Item 1(a). Name of Issuer:**
Alpha Tau Medical Ltd.

**Item 1(b). Address of Issuer's Principal Executive Offices:**
Kiryat HaMada St. 5, Jerusalem, Israel 9777605

**Item 2(a). Name of Person Filing:**
Uzi Sofer (the "Reporting Person")

**Item 2(b). Address of Principal Business Office:**
The principal business address of the Reporting Person is c/o Alpha Tau Medical Ltd., Kiryat HaMada St. 5, Jerusalem 9777605, Israel.

**Item 2(c). Citizenship:**
The Reporting Person is a citizen of the State of Israel.

**Item 2(d). Title of Class of Securities:**
Ordinary Shares, no par value

**Item 2(e). CUSIP Number:**
M0740A108

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

The Reporting Person is the beneficial owner of 13,702,361 Ordinary Shares, which includes 2,187,047 Ordinary Shares underlying restricted stock units vested and stock options exercisable within 60 days of the date hereof.
The ownership information presented herein represents beneficial ownership of Ordinary Shares of the Issuer as of the date hereof, based upon 84,819,996 Ordinary Shares outstanding as of June 20, 2025, as disclosed in the Issuer's Registration Statement on Form F-3 filed with the Securities and Exchange Commission on June 23, 2025.

**(b) Percent of class:**

15.8%

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

13,702,361

**(ii) Shared power to vote or to direct the vote:**

0

**(iii) Sole power to dispose or to direct the disposition of:**

13,702,361

**(iv) Shared power to dispose or to direct the disposition of:**

0

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

Not Applicable

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

—

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Uzi Sofer**

**Date:** 07/24/2025

**By:** /s/ Uzi Sofer

**Name & Title:** Uzi Sofer